BrightPath Biotherapeutics Co Ltd

NEW
TSE:4594 (Japan)  
円 48 +1 (+2.13%) Jul 23
At Loss
P/B:
2.82
Market Cap:
円 6.67B ($ 40.70M)
Enterprise V:
円 4.51B ($ 27.53M)
Volume:
876.40K
Avg Vol (2M):
1.49M
Trade In:

BrightPath Biotherapeutics Co Ltd’s share price is 円48. Its GF Value is 円4.61. Based on the relationship between the current stock price and the GF Value, GuruFocus believes BrightPath Biotherapeutics Co Ltd stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: 円48 GF Value Price/GF Value
Current 円4.61 10.41
Next FY1 End 円3.93 12.21
Next 12 Month 円3.61 13.30
Next FY2 End 円2.95 16.27
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing BrightPath Biotherapeutics Co Ltd's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The findings reveal that BrightPath Biotherapeutics Co Ltd's stock price shows no significant correlation with any of these four metrics.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies